Display options
Share it on

BMC Res Notes. 2010 Feb 23;3:40. doi: 10.1186/1756-0500-3-40.

Emergence of KPC-producing Klebsiella pneumoniae in Italy.

BMC research notes

Carla Fontana, Marco Favaro, Loredana Sarmati, Silvia Natoli, Anna Altieri, Maria C Bossa, Silvia Minelli, Francesca Leonardis, Cartesio Favalli

Affiliations

  1. Department of Experimental Medicine and Biochemical Sciences, "Tor Vergata" University of Rome - Via Montpellier 1, Rome, 00133, Italy. [email protected].

PMID: 20178590 PMCID: PMC2844393 DOI: 10.1186/1756-0500-3-40

Abstract

BACKGROUND: The emergence of KPC-producing K. pneumoniae has now become a global concern. KPC beta-lactamases are plasmid-borne and, like extended spectrum beta lactamases (ESBLs), can accumulate and transfer resistance determinants to other classes of antibiotics. Therefore, infection control guidelines on early identification and control of the spread of organisms carrying these resistant determinants are needed.

FINDINGS: Klebsiella pneumoniae carbapenemase (KPC) was detected in two isolates of carbapenem-resistant K. pneumoniae obtained from patients at an Italian teaching hospital. The first strain was isolated from a culture drawn from a central venous device (CVC) in a patient with Crohn's disease who was admitted to a gastroenterology ward. The second was isolated from a urine sample collected from an indwelling urinary catheter in an intensive care unit (ICU) patient with a subdural haematoma. The patients had not travelled abroad. Both isolates were resistant to all beta-lactams and were susceptible to imipenem and meropenem but resistant to ertapenem. Isolates also showed resistance to other classes of non-beta-lactam antibiotics, such as quinolones, aminoglycosides (with the exception for amikacin), trimethoprim-sulfamethoxazole (TMP-SMX) and nitrofurantoin. They were determined to contain the plasmid encoding the carbapenemase gene bla-KPC and were also positive in the Hodge test.

CONCLUSIONS: This is the second report of KPC-producing isolates in Italy, but the first concerning KPC type 2 gene, and it may have important implications for controlling the transmission of microorganisms resistant to antibiotics.

References

  1. Antimicrob Agents Chemother. 2006 Oct;50(10):3396-406 - PubMed
  2. J Clin Microbiol. 2002 Jun;40(6):2153-62 - PubMed
  3. Antimicrob Agents Chemother. 2005 Feb;49(2):776-8 - PubMed
  4. Euro Surveill. 2009 May 28;14(21): - PubMed
  5. Antimicrob Agents Chemother. 2004 Nov;48(11):4438-40 - PubMed
  6. J Antimicrob Chemother. 2008 Feb;61(2):296-300 - PubMed
  7. J Clin Microbiol. 2009 Nov;47(11):3793-4 - PubMed
  8. Antimicrob Agents Chemother. 2008 Jun;52(6):2014-8 - PubMed
  9. Antimicrob Agents Chemother. 2005 Oct;49(10):4423-4 - PubMed
  10. Clin Infect Dis. 2006 Aug 1;43(3):e26-8 - PubMed
  11. Antimicrob Agents Chemother. 2009 Feb;53(2):557-62 - PubMed
  12. Clin Microbiol Infect. 2001 Feb;7(2):88-91 - PubMed
  13. Antimicrob Agents Chemother. 2007 Apr;51(4):1553-5 - PubMed
  14. Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents - PubMed
  15. J Antimicrob Chemother. 2009 Feb;63(2):265-8 - PubMed
  16. Future Microbiol. 2007 Oct;2(5):501-12 - PubMed
  17. J Clin Microbiol. 2009 Jun;47(6):1920-2 - PubMed
  18. Antimicrob Agents Chemother. 2006 Aug;50(8):2880-2 - PubMed
  19. J Clin Microbiol. 2008 Jun;46(6):2066-9 - PubMed
  20. Antimicrob Agents Chemother. 2001 Apr;45(4):1151-61 - PubMed
  21. J Clin Microbiol. 2007 Aug;45(8):2723-5 - PubMed
  22. Euro Surveill. 2009 Apr 02;14(13): - PubMed
  23. Antimicrob Agents Chemother. 2007 Aug;51(8):3026-9 - PubMed
  24. Emerg Infect Dis. 2006 Aug;12(8):1209-13 - PubMed
  25. Antimicrob Agents Chemother. 2007 Sep;51(9):3440-4 - PubMed
  26. Antimicrob Agents Chemother. 2003 Apr;47(4):1297-300 - PubMed
  27. Antimicrob Agents Chemother. 2008 Apr;52(4):1257-63 - PubMed

Publication Types